Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 30-Sep-24 4:15 PM View:  | Apellis Pharmaceuticals, Inc. (APLS) | 27-Sep-24 | Gift | 10,569 | -- | -- | 5% 197.86K to 208.43K | |
| 30-Sep-24 4:15 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 27-Sep-24 | Gift | 10,569 | -- | -- | (5%) 208.43K to 197.86K | |
| 08-Mar-24 7:45 AM View: | Apellis Pharmaceuticals, Inc. (APLS) | 06-Mar-24 | Option Exercise | 3,762 | $13.85 | $52,103.70 | 2% 194.09K to 197.86K | |
| 13-Feb-24 5:06 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 12-Feb-24 | Private Sale | 781 | $67.77 | $52,925.90 | (< 1%) 194.88K to 194.09K | |
| 31-Jan-24 4:38 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 29-Jan-24 | Private Sale | 906 | $64.14 | $58,109.20 | (< 1%) 195.78K to 194.88K | |
| 23-Jan-24 6:17 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 22-Jan-24 | Private Sale | 4,184 | $65.00 | $271,943.00 | (2%) 199.97K to 195.78K | |
| 17-Jan-24 4:38 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 16-Jan-24 | Grant | 23,748 | -- | -- | 13% 180.46K to 204.21K | |
| 17-Jan-24 4:38 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 16-Jan-24 | Sale | 4,240 | $66.81 | $283,268.00 | (2%) 204.21K to 199.97K | |
| 20-Dec-23 4:18 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 19-Dec-23 | Option Exercise | 7,905 | $13.85 | $109,484.00 | 4% 176.46K to 184.36K | |
| 20-Dec-23 4:18 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 19-Dec-23 | Option Sale | 3,905 | $57.23 | $223,472.00 | (2%) 184.36K to 180.46K | |
| 06-Jul-23 4:20 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 03-Jul-23 | Private Sale (Planned) | 8,510 | $89.98 | $765,730.00 | (5%) 184.97K to 176.46K | |
| 29-Jun-23 4:13 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 28-Jun-23 | Gift | 12,750 | -- | -- | 7% 184.97K to 197.72K | |
| 29-Jun-23 4:13 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 28-Jun-23 | Gift | 12,750 | -- | -- | (6%) 197.72K to 184.97K | |
| 24-Apr-23 4:20 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 21-Apr-23 | Gift | 67,955 | -- | -- | 37% 184.97K to 252.92K | |
| 24-Apr-23 4:20 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 21-Apr-23 | Gift | 67,955 | -- | -- | (27%) 252.92K to 184.97K | |
| 22-Feb-23 6:42 AM View: | Apellis Pharmaceuticals, Inc. (APLS) | 21-Feb-23 | Grant | 9,886 | -- | -- | 6% 175.91K to 185.79K | |
| 22-Feb-23 6:42 AM View: | Apellis Pharmaceuticals, Inc. (APLS) | 21-Feb-23 | Payment of Exercise | 825 | $58.50 | $48,262.50 | (< 1%) 185.79K to 184.97K | |
| 14-Feb-23 5:29 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 10-Feb-23 | Payment of Exercise | 532 | $51.21 | $27,243.70 | (< 1%) 176.44K to 175.91K | |
| 30-Jan-23 5:19 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 27-Jan-23 | Payment of Exercise | 551 | $52.77 | $29,076.30 | (< 1%) 176.99K to 176.44K | |
| 24-Jan-23 5:33 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 20-Jan-23 | Payment of Exercise | 2,034 | $52.05 | $105,870.00 | (1%) 179.02K to 176.99K | |
| 17-Jan-23 7:46 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 12-Jan-23 | Grant | 53,455 | -- | -- | 43% 125.57K to 179.02K | |
| 23-Jun-22 4:22 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 22-Jun-22 | Market Sale | 10,000 | $44.51 | $445,140.00 | (7%) 135.57K to 125.57K | < 1% |
| 27-Apr-22 4:39 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 25-Apr-22 | Sale (Planned) | 5,000 | $50.00 | $250,000.00 | (4%) 140.57K to 135.57K | |
| 27-Apr-22 4:39 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 21-Apr-22 | Disposition (other) | 1,875 | -- | -- | (1%) 142.44K to 140.57K | |
| 14-Feb-22 6:36 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 10-Feb-22 | Payment of Exercise | 491 | $47.12 | $23,135.90 | (< 1%) 142.94K to 142.44K | |
| 01-Feb-22 6:03 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 28-Jan-22 | Payment of Exercise | 650 | $38.59 | $25,083.50 | (< 1%) 143.59K to 142.94K | (15%) |
| 25-Jan-22 4:49 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 21-Jan-22 | Grant | 26,051 | -- | -- | 22% 117.53K to 143.59K | |
| 28-Dec-21 5:38 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 27-Dec-21 | Market Sale | 1,200 | $48.50 | $58,200.00 | (1%) 118.73K to 117.53K | 1% |
| 23-Dec-21 4:58 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 22-Dec-21 | Option Exercise | 20,112 | $14.40 | $289,674.00 | 18% 109.19K to 129.31K | |
| 23-Dec-21 4:58 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 22-Dec-21 | Market Option Sale | 10,571 | $47.81 | $505,373.00 | (8%) 129.31K to 118.73K | |
| 10-Feb-22 10:00 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 08-Dec-21 | Gift | 3,333 | -- | -- | (25%) 13.33K to 10.0K | |
| 13-Sep-21 4:08 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 10-Sep-21 | Option Exercise | 954 | $4.31 | $4,111.74 | < 1% 108.24K to 109.19K | |
| 22-Jun-21 4:02 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 21-Jun-21 | Option Exercise | 489 | $4.31 | $2,107.59 | < 1% 107.75K to 108.24K | |
| 01-Jun-21 4:53 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 28-May-21 | Option Exercise | 489 | $4.31 | $2,107.59 | < 1% 107.26K to 107.75K | |
| 23-Apr-21 4:02 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 22-Apr-21 | Option Exercise | 489 | $4.31 | $2,107.59 | < 1% 106.77K to 107.26K | |
| 23-Mar-21 4:14 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 22-Mar-21 | Option Exercise | 978 | $4.31 | $4,215.18 | < 1% 105.79K to 106.77K | |
| 11-Feb-21 4:02 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 10-Feb-21 | Payment of Exercise | 468 | $47.72 | $22,333.00 | (< 1%) 106.26K to 105.79K | (19%) |
| 01-Feb-21 4:40 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 28-Jan-21 | Grant | 9,375 | -- | -- | 10% 96.89K to 106.26K | |
| 29-Jan-21 4:18 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 27-Jan-21 | Option Exercise | 43,483 | $4.01 | $174,519.00 | 81% 53.4K to 96.89K | |
| 15-Dec-20 4:03 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 14-Dec-20 | Option Exercise | 8,398 | $13.85 | $116,312.00 | 16% 53.4K to 61.8K | |
| 15-Dec-20 4:03 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 14-Dec-20 | Market Option Sale | 8,398 | $52.06 | $437,198.00 | (14%) 61.8K to 53.4K | (9%) |
| 15-Dec-20 4:03 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 11-Dec-20 | Option Exercise | 9,935 | $13.85 | $137,600.00 | 19% 53.4K to 63.34K | |
| 15-Dec-20 4:03 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 11-Dec-20 | Market Option Sale | 9,935 | $50.00 | $496,750.00 | (16%) 63.34K to 53.4K | (14%) |
| 12-Feb-20 4:38 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 10-Feb-20 | Grant | 6,375 | -- | -- | 14% 44.04K to 50.42K | |
| 12-Feb-20 4:38 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 10-Feb-20 | Option Exercise | 7,505 | $2.67 | $20,038.30 | 15% 50.42K to 57.92K | |
| 12-Feb-20 4:38 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 10-Feb-20 | Market Option Sale (Planned) | 5,000 | $44.50 | $222,500.00 | (9%) 57.92K to 52.92K | (28%) |
| 28-Jan-20 5:08 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 27-Jan-20 | Option Exercise | 15,000 | $2.67 | $40,050.00 | 47% 32.04K to 47.04K | |
| 28-Jan-20 5:08 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 27-Jan-20 | Market Option Sale (Planned) | 3,000 | $40.47 | $121,401.00 | (6%) 47.04K to 44.04K | (41%) |
| 09-Aug-19 8:48 AM View: | Apellis Pharmaceuticals, Inc. (APLS) | 07-Aug-19 | Option Exercise | 5,000 | $2.67 | $13,350.00 | 18% 27.04K to 32.04K | |
| 17-Sep-18 5:40 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 14-Sep-18 | Option Exercise | 32,818 | $2.67 | $87,624.10 | 328% 10.0K to 42.82K |